Genome-wide Identification and Characterization of Hsp70 gene family in Pearl millet (Pennisetumglaucum)

Heat shock proteins (Hsps) are a class of molecular chaperons which are crucial for protein folding, assembly, and translocation in many normal cellular processes. They stabilize proteins and membranes, and can assist in protein refolding under stress conditions in plants. Pearl millet (Pennisetum glaucum) is highly abiotic stress tolerant, but its Hsps have not been characterized. In the present study, PgHsp70 genes were retrieved and gene information analyzed in order to characterize their structure, localization and functions. Genome-wide screening using the tools of bioinformatics identified 18 PgHsp70 genes in the pearl millet genome which have been categorized into four subfamilies depending on their cellular localization such as endoplasmic reticulum, mitochondria, chloroplast and cytoplasm. Number of introns ranged from 0-11 in PgHsp70 family genes and the genes are located across 1 to 7 chromosomes. Phylogenetic analysis of Hsp70s revealed that they are closely related to Sorghum Hsp70s. Promoter analysis showed the presence of cisacting elements such as GCN4, HSE, LTR, MBS, ABRE, MYB, and TC Aassociated with abiotic stress conditions indicating the involvement of these genes in the abiotic stress. Under vapour pressure deficit (VPD) conditions, leaf and root tissues of VPD-sensitive ICMR 1152 line, showed mild expression and in the presence of high VPD, VPD-insensitive ICMR1122 PgHsp70 genes showed high expression in leaf and root tissues in comparison with VPD-sensitive line. Gene PgcHsp70-1 displayed high transcript level under high VPD conditions. These results expand our horizon of understanding of the structure and function of Hsp70s, especially under abiotic stress conditions which can further be validated and employed in breeding programs and genetic engineering

An observational cohort study to produce and evaluate an improved tool to screen older women with back pain for osteoporotic vertebral fractures (Vfrac): study protocol.

The aim of this study is to produce an easy to use checklist for general practitioners to complete whenever a woman aged over 65 years with back pain seeks healthcare. This checklist will produce a binary output to determine if the patient should have a radiograph to diagnose vertebral fracture. PURPOSE: People with osteoporotic vertebral fractures are important to be identified as they are at relatively high risk of further fractures. Despite this, less than a third of people with osteoporotic vertebral fractures come to clinical attention due to various reasons including lack of clear triggers to identify who should have diagnostic spinal radiographs. This study aims to produce and evaluate a novel screening tool (Vfrac) for use in older women presenting with back pain in primary care based on clinical triggers and predictors identified previously. This tool will generate a binary output to determine if a radiograph is required. METHODS: The Vfrac study is a two-site, pragmatic, observational cohort study recruiting 1633 women aged over 65 years with self-reported back pain. Participants will be recruited from primary care in two sites. The Vfrac study will use data from two self-completed questionnaires, a simple physical examination, a lateral thoracic and lateral lumbar radiograph and information contained in medical records. RESULTS: The primary objective is to develop an easy-to-use clinical screening tool for identifying older women who are likely to have vertebral fractures. CONCLUSIONS: This article describes the protocol of the Vfrac study; ISRCTN16550671

Subclinical hypothyroidism in women planning conception and during pregnancy: Who should be treated and how?

Subclinical hypothyroidism (SCH), a mild form of hypothyroidism defined as elevated TSH with normal free thyroxine levels, is a common diagnosis among women of reproductive age. In some, but not all, studies, it has been associated with infertility, an increased risk of adverse pregnancy and neonatal outcomes, and possibly with an increased risk of neurocognitive deficits in offspring. Despite wellestablished recommendations on treatment of overt hypothyroid pregnant women, a consensus has not yet been reached on whether to treat women with SCH. This review focuses on examining the evidence informing the clinical strategy for using levothyroxine (LT4) in women with SCH during pregnancy and those who are planning conception. A crucial first step is to accurately diagnose SCH using the appropriate population-based reference range. For pregnant women, if this is unavailable, the recommended TSH upper normal limit cutoff is 4.0 mIU/L. There is evidence supporting a decreased risk for pregnancy loss and preterm delivery for pregnant women with TSH > 4.0 mIU/L receiving LT4 therapy. LT4 treatment has been associated with better reproductive outcomes in women with SCH undergoing artificial reproductive techniques, but not in those who are attempting natural conception. Thyroid function tests need to be repeated throughout pregnancy to monitor LT4 therapy. In addition to potential harms, LT4 contributes to treatment burden. During a consultation, clinicians and patients should engage in a careful consideration of the current evidence in the context of the patients' values and preferences to determine whether LT4 therapy initiation is the best next step. © 2018 Endocrine Society